Quarterly report [Sections 13 or 15(d)]

Subsequent Events (Details)

v3.25.3
Subsequent Events (Details)
$ / shares in Units, $ in Thousands
Oct. 17, 2025
Right
$ / shares
Oct. 13, 2025
$ / shares
shares
Oct. 03, 2025
USD ($)
Aug. 03, 2025
Right
$ / shares
Oct. 09, 2025
USD ($)
Oct. 08, 2025
Sep. 30, 2025
USD ($)
Aug. 20, 2025
USD ($)
$ / shares
Jul. 13, 2025
USD ($)
Dec. 31, 2024
USD ($)
Subsequent Events                    
Acquisition service, arranger fee, receivable | $                 $ 3,000  
Restricted cash | $             $ 45,288     $ 1,330
Employee Stock Option                    
Subsequent Events                    
Stock option, exercise price range, lower limit   $ 4.03                
Stock option, exercise price range, upper limit   $ 5.5                
LAVA                    
Subsequent Events                    
Asset acquisition, share price (in dollars per share)       $ 1.16            
Asset acquisition, share price, purchase price adjustment (in dollars per share)       $ 0.08            
Number of non-transferable contractual CVR per share | Right       1            
Asset acquisition, ownership percentage at acquisition closing (as a percent)       100.00%            
Mural                    
Subsequent Events                    
Asset acquisition, share price (in dollars per share)               $ 2.035    
Asset acquisition, share price, purchase price adjustment (in dollars per share)               $ 0.205    
Asset acquisition, ownership percentage at acquisition closing (as a percent)               100.00%    
Restricted cash | $               $ 39,900    
Subsequent Event | Xeno                    
Subsequent Events                    
Short-term loan | $         $ 5,900          
Subsequent Event | 2025 Common Stock ATM Agreement                    
Subsequent Events                    
Maximum amount of shares to be issued (in shares) | $     $ 75,000              
Subsequent Event | 2025 Series B Preferred Stock ATM Agreement                    
Subsequent Events                    
Maximum amount of shares to be issued (in shares) | $     $ 50,000              
Sale of stock, depository shares, ratio, depository shares to Series B Preferred Stock     0.001              
Subsequent Event | Maximum | Employee Stock Option                    
Subsequent Events                    
Number of shares exchanged for cash | shares   142,278                
Subsequent Event | Maximum | 2025 Common Stock ATM Agreement                    
Subsequent Events                    
Sales commission paid per transaction, preferred stock (as a percent)     3.00%              
Subsequent Event | Maximum | 2025 Series B Preferred Stock ATM Agreement                    
Subsequent Events                    
Sales commission paid per transaction, preferred stock (as a percent)     3.00%              
Subsequent Event | LAVA                    
Subsequent Events                    
Asset acquisition, share price (in dollars per share) $ 1.04                  
Number of non-transferable contractual CVR per share | Right 1                  
Subsequent Event | Essa Pharma Inc | BVF | Related Party                    
Subsequent Events                    
Ownership interest (as a percent)           24.70%